Metraipolis › archive › dc_d48c7489fe10

Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41577858
DOI
10.1007/s12672-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-06T13:12:06.476Z
SHA-256 of the archived text
e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab
Stable URL of this page
https://metraipolis.com/documento/dc_d48c7489fe10

How to cite

Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858 — Europe PMC (en), https://europepmc.org/article/MED/41577858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d48c7489fe10 (Metraipolis archive dc_d48c7489fe10, sha256 e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab)
BibTeX
@misc{dcd48c7489fe10,
  title = {Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment — Europe PMC PMID:41577858},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41577858},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d48c7489fe10; sha256 e00a7b58234f29682cd65d7b9db9c97716f1d458c3e73d99b83a33607c3e76ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41577858. Agents can read the archived copy with the MCP tool read_document.